Showing results (41-50 of 206) with videos related to
Sort By:
Pageof 21
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|May 5, 2016
Drug breakthrough offers hope to arthritis sufferers: qualitative analysis of medical research in UK newspapersHelen Hanson, Nicola O'Brien, Paul Whybrow, et al.Nature Reviews. Rheumatology|October 10, 2022
Precision medicine: the precision gap in rheumatic diseaseChung M A Lin, Faye A H Cooles, John D IsaacsPharmaceutical Statistics|October 23, 2014
R&D productivity rides again?Dennis Lendrem, Stephen J Senn, B Clare Lendrem, et al.Current Rheumatology Reports|December 5, 2023
Role of IFN-α in Rheumatoid ArthritisChung M A Lin, John D Isaacs, Faye A H CoolesArthritis Research & Therapy|December 4, 2013
Effect of tocilizumab on haematological markers implicates interleukin-6 signalling in the anaemia of rheumatoid arthritisJohn D Isaacs, Olivier Harari, Uwe Kobold, et al.Annals of the Rheumatic Diseases|November 12, 2010
Efficacy of a single ultrasound-guided injection for the treatment of hip osteoarthritisIsmaël Atchia, David Kane, Mike R Reed, et al.Arthritis Research & Therapy|May 4, 2013
What can rheumatologists learn from translational cancer therapy?Jonathan P Sherlock, Andrew D Filer, John D Isaacs, et al.Annals of the Rheumatic Diseases|September 24, 2009
Tumour necrosis factor alpha blockade impairs dendritic cell survival and function in rheumatoid arthritisHelen M Baldwin, Toshiko Ito-Ihara, John D Isaacs, et al.Annals of the Rheumatic Diseases|June 17, 2010
Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritisRachel A Harry, Amy E Anderson, John D Isaacs, et al.Human Vaccines & Immunotherapeutics|February 19, 2014
Emerging immunotherapies for rheumatoid arthritisGary Reynolds, Faye A H Cooles, John D Isaacs, et al.Pageof 21